SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-107015
Filing Date
2024-04-23
Accepted
2024-04-23 16:11:06
Documents
16
Period of Report
2024-04-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d797498d8k.htm   iXBRL 8-K 29928
2 EX-99.1 d797498dex991.htm EX-99.1 243309
6 GRAPHIC g797498g04g04.jpg GRAPHIC 7294
7 GRAPHIC g797498g41g41.jpg GRAPHIC 7337
  Complete submission text file 0001193125-24-107015.txt   468323

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20240409.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20240409_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20240409_pre.xml EX-101.PRE 10807
20 EXTRACTED XBRL INSTANCE DOCUMENT d797498d8k_htm.xml XML 3576
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 24864923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)